Lv2
130 积分 2023-08-09 加入
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
2天前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
1个月前
已完结
Phase I study of CN201, a novel CD3xCD19 bispecific antibody, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
1个月前
已完结
Phase I study of CN201, a novel CD3xCD19 IgG4 bispecific antibody, in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia
1个月前
已完结
Phase I study of CN201, a novel CD3xCD19 IgG4 bispecific antibody, in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia
1个月前
已完结
Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti‐CD20 × anti‐CD3), mediates efficient killing of B‐cell lymphoma cells even with very low CD20 expression levels
2个月前
已完结
Acute lymphoblastic leukaemia
2个月前
已完结
Effects of rituximab therapy on B cell differentiation and depletion
3个月前
已完结
Lessons for rituximab therapy in patients with rheumatoid arthritis
3个月前
已完结
Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus: A Review. JAMA. 2024;331(17):1480–1491. doi:10.1001/jama.2024.2315
3个月前
已完结
皖公网安备34019202002308
